SARS-Cov-2

Patients diagnosed with COVID-19 during the first 3 months of the pandemic had a twofold higher risk for developing alcohol use disorder, likely driven by anxiety and fear surrounding the pandemic, according to new research.

In the early months of 2020, amid a rapidly worsening pandemic, the U.S. government declared public health and national emergencies to help the country respond to COVID-19.

As the COVID-19 pandemic heads into its 4th year, it is a good time to reflect on strides made for those with mild-to-moderate disease not requiring hospitalization.

As the world continues to grapple with effects of the COVID-19 pandemic, individuals around the globe are still dealing with symptoms of SARS-CoV-2 infection for months, even years, after their initial infection.

People with MS who are being treated with rituximab are strongly encouraged to receive mRNA SARS-CoV-2 vaccines and booster doses more than 6 months after their last rituximab infusion, researchers reported in JAMA Network Open.

According to the CDC, up to 3 million serious infections occur every year in nursing homes, skilled nursing facilities and assisted living facilities.

COVID-19 placed a strain on infection prevention and control programs, highlighting vulnerabilities that existed before the pandemic, according to experts.

Healio Pulmonology has compiled the top news on COVID-19 posted in 2022.

Patients who died of COVID-19 had a high expression of MUC5B in their lungs and mucus accumulation in distal airways, according to a study published in American Journal of Respiratory and Critical Care Medicine.

Stressors in life can contribute to poor functional, cognitive and neuropsychiatric outcomes up to a year after being hospitalized with COVID-19, researchers reported in the Journal of Neurological Science.